Country of origin · Allergan Aesthetics
HArmonyCa Lidocaine is Allergan Aesthetics’ hybrid injectable facial implant: calcium hydroxyapatite (CaHA) microspheres suspended in a cross-linked sodium hyaluronate (HA) gel, with lidocaine hydrochloride. The HA component is positioned for immediate soft-tissue support; the CaHA microspheres are positioned for collagen-associated support as the implant resorbs. This is not a PLLA powder, not a liquid PCL (Gouri), and not a low-fraction CaHA-in-HA gel (HYALMASS CaHA+). Box: 2 × 1.25 mL pre-filled syringes.
Allergan IFU (HArmonyCa Lidocaine, F206, June 2024) lists: CaHA microspheres 25–45 µm at 55.7%, cross-linked sodium hyaluronate gel 20 mg/mL, phosphate buffer, lidocaine hydrochloride 3 mg/mL (0.3% w/v). Pack: two 1.25 mL graduated glass syringes and two single-use 27G ½″ thin-wall sterile needles. Versus Radiesse, the carrier is cross-linked HA rather than CMC, and lidocaine is in the gel. Versus HYALMASS CaHA+, the CaHA fraction on the IFU is 55.7%, not a ~5% / 95% HA-dominant hybrid. Confirm the current carton and IFU in the destination market; registration is not global.
Why clinics stock HArmonyCa Lidocaine
·
·
·
·
How HArmonyCa Lidocaine is described
The IFU describes a sterile, apyrogenic, viscous, opaque, latex-free, biodegradable semi-solid implant for facial soft-tissue augmentation. Cross-linked HA forms the gel vehicle; CaHA microspheres (25–45 µm) are suspended in that gel; lidocaine is included to reduce treatment discomfort. This listing does not publish injection maps, planes, volumes or reconstitution. Licensed practitioners follow the current IFU for the lot they open.
Intended use (from the IFU — not a protocol)
The IFU indicates facial soft-tissue augmentation. It also lists sites that are contraindicated for this implant, including the glabellar and periocular areas, the lips and perioral region, regions containing foreign bodies, and intravascular injection. Area selection remains a professional decision against the delivered IFU and local labelling. This page is not a treatment map.
HArmonyCa Lidocaine specifications
Where this SKU is typically listed
Precautions
HArmonyCa Lidocaine — frequently asked questions
Two 1.25 mL pre-filled syringes and two 27G ½″ thin-wall sterile needles. That is the Allergan pack described on the IFU and on the supplied carton (2 × 1.25 ml).
HYALMASS CaHA+ (FF-HYLM-2MLX1) is a Korean hybrid listed on this site as roughly 5% CaHA in ~95% cross-linked HA, 1 × 1.2 mL. HArmonyCa’s IFU lists 55.7% CaHA microspheres in HA 20 mg/mL plus lidocaine, 2 × 1.25 mL, Allergan. Same parent category, different fraction, pack and maker.
Radiesse is a CaHA implant in a carboxymethylcellulose carrier. HArmonyCa suspends CaHA in cross-linked HA and includes lidocaine in the gel. Do not substitute them by the word “CaHA” alone.
Gouri is a fully liquid PCL collagen regenerator (1 mL). AestheFill is a PDLLA powder vial that is reconstituted. HArmonyCa is a ready-to-use HA + CaHA gel in syringes.
The IFU states that correction is temporary and varies with the defect, tissue stress, implant depth and technique. Some Allergan communications discuss collagen-associated lift over subsequent months. This listing does not treat 12, 18 or 24 months as a guaranteed interval.
A trained, licensed practitioner, following the current IFU and local device rules. Not for retail sale to the public.
Related biostimulators on this site


Reviews
There are no reviews yet.